MENU
+Compare
PEN
Stock ticker: NYSE
AS OF
Jul 9, 03:26 PM (EDT)
Price
$244.06
Change
-$3.74 (-1.51%)
Capitalization
8.64B

PEN Penumbra Forecast, Technical & Fundamental Analysis

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets... Show more

PEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PEN with price predictions
Jul 08, 2025

PEN's Indicator enters downward trend

The Aroon Indicator for PEN entered a downward trend on July 08, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 183 similar instances where the Aroon Indicator formed such a pattern. In of the 183 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 01, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PEN as a result. In of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PEN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where PEN's RSI Oscillator exited the oversold zone, of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for PEN just turned positive on June 16, 2025. Looking at past instances where PEN's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PEN advanced for three days, in of 318 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PEN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PEN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.138) is normal, around the industry mean (24.348). P/E Ratio (93.703) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (8.052) is also within normal values, averaging (42.660).

View a ticker or compare two or three
PEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PEN is expected to report earnings to 82 cents per share on July 29

Penumbra PEN Stock Earnings Reports
Q2'25
Est.
$0.83
Q1'25
Beat
by $0.16
Q4'24
Beat
by $0.07
Q3'24
Beat
by $0.16
Q2'24
Beat
by $0.08
The last earnings report on April 23 showed earnings per share of 82 cents, beating the estimate of 67 cents. With 66.57K shares outstanding, the current market capitalization sits at 8.64B.
A.I. Advisor
published General Information

General Information

a manufacturer of medical devices

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
One Penumbra Place
Phone
+1 510 748-3200
Employees
4200
Web
https://www.penumbrainc.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ANWFX69.450.04
+0.06%
American Funds New Perspective F2
DNLAX42.51N/A
N/A
BNY Mellon Natural Resources A
MNVRX29.98N/A
N/A
Madison Large Cap R6
CICGX10.90N/A
N/A
AB Concentrated International Growth C
JANWX122.07-0.10
-0.08%
Janus Henderson Global Research D

PEN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PEN has been loosely correlated with BSX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if PEN jumps, then BSX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PEN
1D Price
Change %
PEN100%
-0.23%
BSX - PEN
40%
Loosely correlated
-1.37%
ISRG - PEN
39%
Loosely correlated
-1.39%
BIO - PEN
38%
Loosely correlated
+1.49%
MMSI - PEN
37%
Loosely correlated
+4.63%
NVST - PEN
37%
Loosely correlated
+2.44%
More